The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Clinical toxicology (Philadelphia, Pa.) 2019 Feb 26;;1-6 — 2019 Feb 26 — 1-6
Clinical images in medical toxicology: heroin overdose with non-cardiogenic pulmonary edema.
Clinical toxicology (Philadelphia, Pa.) 2006;44;399 — 2006 — 399
Thoracic complications of illicit drug use: an organ system approach.
Radiographics : a review publication of the Radiological Society of North America, Inc 2002 Oct;22 Spec No;S119-35 — 2002 Oct — S119-35
Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain.
Pain 1989 Dec;39;297-300 — 1989 Dec — 297-300
Acute pulmonary edema following naloxone reversal of high-dose morphine anesthesia.
Anesthesiology 1977 Oct;47;376-8 — 1977 Oct — 376-8